SEC Form 4 · accession 0001209191-17-052626
Orthofix Medical Inc. · OFIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Bradley V. Niemann
Officer — President Biostim
Period of report
Sep 11, 2017
Accepted (ET)
Sep 13, 2017 · 4:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000884624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF2 | Sep 11, 2017 | S | 6,956 | $49.4431 | D | 40,178 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale of shares reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 10, 2017.
- F2The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.19 to $49.81, inclusive. The reporting person undertakes to provide to Orthofix International, N.V., any security holder of Orthofix International N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.